Key Insights

Highlights

Research Leaders

6 sponsors active, led by University Hospital, Toulouse

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03187886TerminatedPrimary

Use Lay Language. CAA-ri : a Series of 28 Patients

Showing all 1 trials

Research Network

Active Sponsors

  • University Hospital, Toulouse1
  • Perpignan Hospital Center1
  • Narbonne Hospital1
  • Beziers Hospital1
  • Centre Hospitalier Universitaire de Nīmes1

Top Investigators

Activity Timeline